Genetic polymorphisms associated with overweight and obesity in uncontrolled Type 2 diabetes mellitus. (April 2016)

• Record Type: Journal Article
• Authors: Kasim, Nor Bahirah; Huri, Hasniza Zaman; Vethakkan, Shireene Ratna; Ibrahim, Luqman; Abdullah, Bashar Mudhaffar
• Is Part Of: Biomarkers in medicine. Volume 10:Number 4(2016)
• Page Start: 403
• Page End: 415
• Publication Date: 2016-04
• Subjects: ADIPOQ -- genetic polymorphisms -- GRB14 -- insulin resistance -- IRS2 -- LEPR -- obesity -- overweight -- PPARG -- uncontrolled T2DM; Biochemical markers -- Periodicals; 610.28
• DOI: 10.2217/bmm-2015-0037
• Languages: English
• ISSNs: 1752-0363

Abstract

Generally, obese and overweight individuals display higher free fatty acid levels, which stimulate insulin resistance. The combination of overweight or obesity with insulin resistance can trigger Type 2 diabetes mellitus (T2DM) and are primary contributing factors to the development of uncontrolled T2DM. Genetic polymorphisms also play an important role as they can impact a population's susceptibility to becoming overweight or obese and developing related chronic complications, such as uncontrolled T2DM. This review specifically examines the genetic polymorphisms associated with overweight and obesity in patients with uncontrolled T2DM. Particularly, gene polymorphisms in ADIPOQ (rs1501299 and rs17300539), LepR (rs1137101 and rs1045895), IRS2 (rs1805092), GRB14 (rs10195252 and rs3923113) and PPARG (rs1801282) have been associated with overweight and obesity in uncontrolled T2DM.